Literature DB >> 11477395

New nomenclature for MHC receptors.

P André1, R Biassoni, M Colonna, D Cosman, L L Lanier, E O Long, M Lopez-Botet, A Moretta, L Moretta, P Parham, J Trowsdale, E Vivier, N Wagtmann, M J Wilson.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11477395     DOI： 10.1038/90589

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  12 in total

1.  Polarization and reprogramming of myeloid-derived suppressor cells.

Authors:  Wen-Chin Yang; Ge Ma; Shu-Hsia Chen; Ping-Ying Pan
Journal:  J Mol Cell Biol       Date:  2013-03-25       Impact factor: 6.216

2.  Comparative analysis of NK-cell receptor expression and function across primate species: Perspective on antiviral defenses.

Authors:  Roberto Biassoni; Elisabetta Ugolotti; Andrea De Maria
Journal:  Self Nonself       Date:  2010-03-06

3.  Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation.

Authors:  Selim Kuçi; Eva Rettinger; Bernhard Voss; Gerrit Weber; Miriam Stais; Hermann Kreyenberg; Andre Willasch; Zyrafete Kuçi; Ewa Koscielniak; Stephan Klöss; Dorothee von Laer; Thomas Klingebiel; Peter Bader
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941

4.  Chronic and recurrent otitis media: a genome scan for susceptibility loci.

Authors:  Kathleen A Daly; W Mark Brown; Fernando Segade; Donald W Bowden; Bronya J Keats; Bruce R Lindgren; Samuel C Levine; Stephen S Rich
Journal:  Am J Hum Genet       Date:  2004-10-22       Impact factor: 11.025

5.  Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

Authors:  Steven G E Marsh; Peter Parham; Bo Dupont; Daniel E Geraghty; John Trowsdale; Derek Middleton; Carlos Vilches; Mary Carrington; Campbell Witt; Lisbeth A Guethlein; Heather Shilling; Christian A Garcia; Katharine C Hsu; Hester Wain
Journal:  Immunogenetics       Date:  2003-06-28       Impact factor: 2.846

6.  The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma.

Authors:  Rosa Nguyen; Jim Houston; Wing K Chan; David Finkelstein; Michael A Dyer
Journal:  Cancer Immunol Immunother       Date:  2018-01-11       Impact factor: 6.968

7.  Association of killer cell immunoglobulin-like receptors with endemic Burkitt lymphoma in Kenyan children.

Authors:  Beatrice M Muriuki; Catherine S Forconi; Peter O Oluoch; Jeffrey A Bailey; Anita Ghansah; Ann M Moormann; John M Ong'echa
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

8.  LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.

Authors:  Myongchol Ryu; Yong Chen; Jianxun Qi; Jun Liu; Zheng Fan; Gol Nam; Yi Shi; Hao Cheng; George F Gao
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

9.  Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells.

Authors:  Melissa R Snyder; Mathias Lucas; Eric Vivier; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

10.  Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.

Authors:  Caroline Besson; Sophie Roetynck; Fionnuala Williams; Laurent Orsi; Corinne Amiel; Catherine Lependeven; Guillemette Antoni; Olivier Hermine; Pauline Brice; Christophe Ferme; Patrice Carde; Danielle Canioni; Josette Brière; Martine Raphael; Jean-Claude Nicolas; Jacqueline Clavel; Derek Middleton; Eric Vivier; Laurent Abel
Journal:  PLoS One       Date:  2007-05-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.